https://www.selleckchem.com/pr....oducts/netarsudil-ar
Risk reduction surgery occurred more often in participants with tier 1 than those with non-tier 1 variants. Relevant phenotypic traits were observed in 57% whereas a clinical outcome occurred in 19% of participants with actionable genomic variants in the year following RoR. Relevant phenotypic traits were observed in 57% whereas a clinical outcome occurred in 19% of participants with actionable genomic variants in the year following RoR. To elucidate the novel molecular cause in families with a new autosomal recessive neurod
Like
Comment
Share
